XDH and congestive heart failure: Owing to promising results of preliminary studies, Hare et al. conducted the Oxypurinol Therapy for Congestive Heart Failure (OPT-CHF) trial, a randomized controlled trial (RCT), to study the hypothesized benefit of XO inhibition (oxypurinol) on mortality in CHF [134].